Fundraising Fox
Pexmachina
5 employees on LinkedIn · 1 known investors
Find your way into Pexmachina
Sign up to see every warm intro you have to Pexmachina
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pexmachina team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PexMachina develops physics-based molecular simulation for drug discovery, using quantum-ready computational chemistry and AI agents to predict properties like binding, stability, and oral availability of peptides. It delivers its PexAgent as an MCP service that integrates into LLM platforms such as Claude and Gemini, letting pharmaceutical researchers run molecular simulations via natural language within existing R&D workflows.
Founders & leadership
MK
Matthias KaiserFounderMatthias Kaiser holds a Master's degree in Physics with a focus on theoretical quantum information theory from the University of Vienna. He has over 13 years of experience in business development and commercialization in tech and deep-tech sectors, and previously founded a company in industrial optimization and AI before starting PexMachina.
Investors · 1
Frequently asked questions
- What does Pexmachina do?
- PexMachina develops physics-based molecular simulation for drug discovery, using quantum-ready computational chemistry and AI agents to predict properties like binding, stability, and oral availability of peptides. It delivers its PexAgent as an MCP service that integrates into LLM platforms such as Claude and Gemini, letting pharmaceutical researchers run molecular simulations via natural language within existing R&D workflows.
- Who founded Pexmachina?
- Pexmachina was founded by Matthias Kaiser.
- Who are Pexmachina's investors?
- Pexmachina's investors include QAI Ventures.